baber/WOPTO huggingface dataset:
Patent AU-728955-B2 (AU)
Title: Catheter with stand-off structure
Inventor: LIPRIE SAMUEL F
IPC: A61N5/10
Filed: 1998-09-23
Granted: 2001-01-25
Abstract: A catheter (10), and a method for performing radiation treatment at a site where angio-plasty was performed, are disclosed. The catheter (10) includes a hollow, cylindrical member (12) constructed from a fairly flexible material. The catheter is maneuvered within the body by traveling over a guide wire which was initially maneuvered in the blood vessel to a position beyond the actual site of a stenosis. Stand-off structure (26) having a stand-off balloon (28) surrounds a portion (30) of the outer surface of the catheter (10). The distal end (18) of the catheter (10) includes an inner lumen plug (38), and a distal mandrel (40) extending through the inner lumen plug (38). The distal mandrel (40) is manufactured from shape memory alloy to stiffen, and reinforce the catheter when the catheter is introduced within the blood vessel.
Patent AU-566643-B2 (AU)
Title: Pentapeptides as analgesics
Inventor: LOWE LAWRENCE ALFRED
IPC: C07K1/113
Filed: 1983-02-04
Granted: 1987-10-29
Abstract: Novel peptides of formula (I)and salts thereof, wherein X is hydrogen or an amidino group and X<sup>2</sup> is a radical selected from D-S-methylmethionyl and D-arginyl, have a selectively peripheral analgesic effect when administered to mammals.The compounds also exhibit antidiarrhoeal and antitussive activity and may thus be used in human or veterinary medicine for the relief or prevention of pain, for the treatment of diarrhoea or dysentery and for the suppression of cough.
Patent AU-757428-B2 (AU)
Title: Tubular element with sealing means and a method for manufacturing the tubular element
Inventor: MATTSSON LARS-AKE
IPC: F24F13/02
Filed: 1999-11-04
Granted: 2003-02-20
Abstract: A sealing ring to be mounted on the outside of a tubular element (11) for use in a fluid-conducting duct system comprises a base (13) with a fastening section which is adapted to be clamped by an end portion (18) of the tubular element (11), and a sealing section having at least one sealing lip (16) adapted to seal against the inner surface of an outer tube, in which the tubular element (11) is inserted. The sealing section comprises a main sealing lip (14) extending substantially radially away from the base (13) of the sealing ring (10), and at least one intermediate sealing lip (16) which is disposed between the main sealing lip (14) and the fastening section and which extends substantially radially away from the base (13) of the sealing ring (10). The intermediate sealing lip (16) is adapted to seal against the inner surface of the outer tube. <IMAGE>
Patent AU-647619-B2 (AU)
Title: Intramedullary intertrochanteric fracture fixation appliance
Inventor: LAWES PETER
IPC: A61B17/17
Filed: 1992-05-12
Granted: 1994-03-24
Abstract: An intramedullary intertrochanteric fracture fixation appliance comprising an intramedullary rod (1) having an angulated opening (2) to receive a femoral neck screw (7) having a threaded portion (8) at its distal end, and locking means (10) acting between the neck screw and the wall of the angulated opening to prevent relative rotation between the screw and the rod. <IMAGE>
Patent AU-662523-B2 (AU)
Title: Zinc-salts of certain mercapto compounds as antioxidants for high temperature aging of thermoplastic elastomers
Inventor: BERTA DOMINIC A
IPC: C08K5/378
Filed: 1992-05-14
Granted: 1995-09-07
Abstract: Disclosed are dynamically partially or fully crosslinked thermoplastic elastomers, having incorporated therein zinc salts of certain mercapto compounds.
Patent AU-600135-B2 (AU)
Title: Process for pattern dyeing of textile materials
Inventor: GREGORY RICHARD VICTOR
IPC: D06P5/00
Filed: 1988-05-30
Granted: 1990-08-02
Abstract: A process is provided for the pattern dyeing of textile materials (81) wherein dye migration may be inhibited by the in-situ formation of a coordination complex of metal-thickener-dye when the dye-thickener solution is applied to the textile material pretreated with an aqueous solution of a water soluble salt of the metal (88). The metal is selected from zirconium, hafnium or aluminum. The thickener may be a naturally derived aqueous system thickener, such as guar gum, xanthan gum or other water-soluble gum thickener or may be a synthetically derived aqueous system thickener, such as polyacrylics and polyacrylamides.
Patent AU-655475-B2 (AU)
Title: WC module with WC bowl forming part of wall construction
Inventor: KORDELIN TAPIO
IPC: A47K13/14
Filed: 1992-06-02
Granted: 1994-12-22
Abstract: PCT No. PCT/FI92/00173 Sec. 371 Date Nov. 29, 1993 Sec. 102(e) Date Nov. 29, 1993 PCT Filed Jun. 2, 1992 PCT Pub. No. WO92/22713 PCT Pub. Date Dec. 23, 1992.A WC module which is ready to be installed into place and to be connected to the water and sewer connections is described. The module has been formed so that its inner wall and WC bowl are of the same piece. Above the WC bowl are situated seat boards which are fixed to the inner wall by a hinge so that the seat boards can be turned into an upright position when they are not in use. The module is formed of two elements in the rear part of which are situated the technical devices relating to the functioning of the WC module, such as the WC bowl, the water tank, etc., and the front part of which incorporates a door.
Patent AU-623080-B2 (AU)
Title: Use of an agent with a high affinity for tumours
Inventor: KARONEN SIRKKA-LIISA
IPC: A61K38/00
Filed: 1988-07-08
Granted: 1992-05-07
Abstract: The vehicle consists of tissue plasminogen activator or an essential part thereof and is used both for the diagnosis and therapy of malignant tumours.
Patent AU-611696-B2 (AU)
Title: Clock signal generation system
Inventor: FUKAZAWA KAZUO
IPC: H04N9/804
Filed: 1988-07-15
Granted: 1991-06-20
Abstract: A television receiver includes a phase-locked loop (PLL) (226-232) which generates a clock signal (CLK) having a frequency of N times the line frequency and being phase-locked to the horizontal line synchronizing signal (HSYNC). The clock signal produced by this PLL has a frequency which tends to jitter between N+1 and N-1 times the line frequency. To compensate for this jittering in the frequency of the clock signal, phase alignment circuitry (236) is coupled to the PLL to align the phase of the clock signal to the horizontal drive signal (HD) produced by the PLL on the occurrence of each horizontal drive pulse. The PLL may also include a delay element (234) which delays the horizontal drive signal applied to the phase comparator of the PLL. This delay element effectively advances the phase of the horizontal drive signal and the line-locked clock signal with respect to the horizontal sync signal to compensate for signal processing delays imparted in the generation of the horizontal drive signal and the clock signal.
Patent AU-708053-B2 (AU)
Title: Piperazine and piperidine compounds
Inventor: FEENSTRA ROELOF WILLEM
IPC: A61K31/00
Filed: 1997-03-20
Granted: 1999-07-29
Abstract: The invention relates to a group of new piperazine and piperidine compounds having interesting pharmacological properties. It has been found that compounds of formula (a) wherein A represents a heterocyclic group of 5-7 ring atoms wherein 1-3 heteroatoms from the group O, N and S are present; R1 is hydrogen or fluoro; R2 is C1-4-alkyl, C1-4-alkoxy or an oxo group, and p is 0, 1 or 2; Z represents carbon or nitrogen, and the dotted line is a single bond when Z is nitrogen, and a single or double bond when Z is carbon; R3 and R4 independently are hydrogen or C1-4-alkyl; n has the value 1 or 2; R5 is halogen, hydroxy, C1-4-alkoxy or C1-4-alkyl, and q is 0, 1, 2 or 3; Y is phenyl, furanyl or thienyl, which groups may be substituted with 1-3 substituents of the group hydroxy, halogen, C1-4-alkoxy, C1-4-alkyl, cyano, aminocarbonyl, mono- or di-C1-4-alkylaminocarbonyl; and salts thereof show high affinity for both the dopamine D2 and serotonin 5-HT1A receptors.
Patent AU-693183-B2 (AU)
Title: Candy with tooth plaque neutralising effect
Inventor: KAUFMANN KONRAD
IPC: A61K8/24
Filed: 1995-04-07
Granted: 1998-06-25
Abstract: PCT No. PCT/CH95/00078 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Apr. 7, 1995 PCT Pub. No. WO95/28910 PCT Pub. Date Nov. 2, 1995A candy is disclosed which neutralizes plaque and contains at least one acid neutralizing substance such as an ammonium salt and may further comprise an alkaline metal salt and an alkaline earth metal salt with sugar substitutes and other ingredients.
Patent AU-615937-B2 (AU)
Title: Platinum pharmaceuticals
Inventor: TALEBIAN ABDOLHOSSEN
IPC: A61K31/7135
Filed: 1988-07-18
Granted: 1991-10-17
Abstract: Platinum compounds useful in the treatment of cancer are disclosed. Compositions containing these compounds and methods of using the same are also discussed. Platinum compounds of formula (I) and (II) and (III) are disclosed. Compositions containing these compounds and methods of using the same are also discussed.
Patent AU-659198-B2 (AU)
Title: Use of crystalline molecular sieves containing charged octahedral sites in cyclic desiccating processes
Inventor: KUZNICKI STEVEN M
IPC: B01D53/26
Filed: 1992-06-16
Granted: 1995-05-11
Abstract: Crystalline molecular sieves containing octahedral sites such as the sieves known as ETS-4, ETS-10 and ETAS-10 are used to remove water from gases at ambient temperature and are regenerated by drying at mild temperatures, e.g., 100  DEG C and below, in appropriately modified forms. Processes included adsorptive drying, pressure swing drying, dehumidification, adsorption heat pump, desiccant cooling and water collection.
Patent AU-608723-B2 (AU)
Title: Sulfoaroyl end-capped ester oligomers suitable as soil release agents in detergent compositions and fabric-conditioner articles
Inventor: MALDONADO RENE
IPC: C11D3/00
Filed: 1988-10-04
Granted: 1991-04-11
Abstract: Anionic, especially sulfoaroyl, NaO3S(C6H4)C(O)- preferred, end-capped esters useful as soil release agents in detergent compositions and fabric-conditioner articles. The terephthalate esters contain unsymmetrically substituted oxy-1,2-alkyleneoxy units (oxy-1,2-propyleneoxy units preferred).
Patent AU-690267-B2 (AU)
Title: Multi token gaming method
Inventor: BLUMBERG BARRY B
IPC: A63F9/24
Filed: 1995-05-02
Granted: 1998-04-23
Abstract: A promotional game wherein prizes are automatically and randomly awarded upon presentation of multiple tokens bearing machine readable codes. The random generation of prize awards will take place after the multiple inputs of machine readable codes include a set of inputs which match a preselected set of actuating codes.
Patent AU-625858-B2 (AU)
Title: Method and compositions relating to regression-associated antigens
Inventor: FAREED GEORGE C
IPC: C07K16/30
Filed: 1988-09-16
Granted: 1992-07-16
Abstract: Regression associated antigens (RAAs) are identified in material from neoplastic cells by their immunological reactivity with regression associated antibodies from the serum of patients diagnosed as undergoing regression of a tumor. Regression associated antibodies (RAAbs) are identified by their absence during progression of a neoplastic disease state and by their presence in a diagnosed state of regression. The antigens are purified, used to monitor the condition of cancer patients, and production of antibodies and treatments employing those antibodies are described. It is also disclosed that RAAs are expressed by M. hyorhinis and may be expressed by expression of provided nucleotide sequences in recombinant host cells. RAAs and nucleic acids encoding RAAs (or portions thereof) and RAAbs may be used in diagnostic assays and immunotherapy. RAAbs and fragments portion thereof may be used in passive immunization therapy and radioisotope or magnetic resonance scanning. A monoclonal RAAb and a hybrdoma secreting it are also provided.
Patent AU-759878-B2 (AU)
Title: Process for producing simvastatin and/or its derivatives
Inventor: DALEN FRANS VAN
IPC: C07C235/30
Filed: 1999-03-05
Granted: 2003-05-01
Abstract: Process for the preparation of a compound of formula (VI), comprising the steps of: reacting a compound of general formula (I) with a ring-opening agent to provide a compound having general formula (II); protecting the hydroxy groups of the thus formed compound (II) with a pre-determined protective agent in order to substantially retard the reactivity thereof and provide a compound having general formula (III) or (VII), wherein the protective agent retards the reactivity of compound (II) by replacing the hydrogen atom of at least one of the hydroxy groups thereof with a carbon terminated group, whereby, in the case of compound (III) at least one of R<3> and R<4> is not hydrogen; reacting compound (III) and/or (VII) with an alkylating agent of formula R<7>X to obtain a compound having formula (IV) or (VIII) respectively, wherein R<7> preferably represents a methyl or ethyl group and X represents a halide, preferably chlorine, bromine or iodine; hydrolyzing the protective groups R<3>, R<4> and R<5>, R<6> of compounds (IV) and (VIII) respectively to obtain a compound of formula (V); relactonizing compound (V) to yield compound (VI).
Patent AU-695387-B2 (AU)
Title: Optical inspection of container finish dimensional parameters
Inventor: RINGLIEN JAMES A
IPC: G01B11/02
Filed: 1995-08-22
Granted: 1998-08-13
Abstract: Apparatus (10) for inspecting external dimensional parameters of a container finish (12) that includes a light source (16) for directing light energy onto the finish (12) of the container (14) and a matrix array sensor (24) disposed to receive an image of the container finish illuminated by the light source. A telecentric lens (32) is positioned to focus onto the matrix array sensor (24) an image (42) of the container finish profile formed by light energy traveling parallel to the telecentric lens axis, such that the finish profile appears as a dark image against a light background at the sensor. The matrix array sensor is scanned at increments of container rotation to determine one or more dimensional parameters of the container finish.
Patent AU-773173-B2 (AU)
Title: Process for preparing non-proteinogenic L-amino acids
Inventor: MAIER THOMAS
IPC: C12P13/04
Filed: 2002-04-04
Granted: 2004-05-20
Abstract: Non-protein L-amino acids (I) are produced by the reaction of O-acetyl-L-serine (II) with a nucleophile (III) in the presence of a catalyst comprising O-acetyl-L-serine sulfhydrylase at pH 5-7.4.
Patent AU-725821-B2 (AU)
Title: Mutated nonactivating IgG2 domains and anti-CD3 antibodies incorporating the same
Inventor: TSO J YUN
IPC: C07K16/46
Filed: 1997-05-19
Granted: 2000-10-19
Abstract: The invention provides mutated IgG2 constant regions and anti-CD3 antibodies incorporating the same. Such antibodies specifically bind to the CD3 antigen on T-cells but induce reduced mitogenic response compared with otherwise identical antibodies bearing natural IgG2 constant regions. The antibodies can be used for treating disorders requiring immune suppression with fewer side effects than result from treatment with prior anti-CD3 antibodies.
Patent AU-663837-B2 (AU)
Title: Extrusion die and an extrusion method using same
Inventor: YANO SADAHIDE
IPC: B21C25/00
Filed: 1993-04-16
Granted: 1995-10-19
Abstract: A female die (3) is composed of a plate-shaped bearing tip (31), a backup block (32) and a cylindrical holder (33) for receiving and setting in place the tip together with the block, in which the bearing tip (31) made of a hard metal and the backup block (32) also made of the hard metal are such that they can be manufactured simply and easily, and in which only the bearing tip (31) need be replaced with a new one if and when the bearing portion of the die has been abraded. <IMAGE>
Patent AU-707669-B2 (AU)
Title: Process for the preparation of an iron-based powder
Inventor: ARVIDSSON JOHAN
IPC: C21D3/04
Filed: 1997-07-18
Granted: 1999-07-15
Abstract: The invention concerns a process for producing a low-oxygen, low-carbon iron-based powder. The process comprises the steps of preparing a powder essentially consisting of iron and optionally at least one alloying element selected from the group consisting of chromium, manganese, copper, nickel, vanadium, niobium, boron, silicon, molybdenum, tungsten, decarburizing the powder in an atmosphere containing at least H2 and H2O gases, measuring the concentration of at least one of the carbon oxides (alternatively gases) formed during the decarburisation process, or measuring the oxygen potential in at least 2 points located at a predetermined distance from each other in the longitudinal direction of the furnace, adjusting the content of the H2O gas in the decarburizing atmosphere with the aid of the measurement. Another alternative concerns measuring the carbon oxides in combination with measuring the oxygen potential.
Patent AU-714966-B2 (AU)
Title: Detection and treatment of cancer
Inventor: MORO RICARDO J
IPC: G01N33/574
Filed: 1995-09-18
Granted: 2000-01-13
Abstract: A method for detecting cancer in a patient. The method comprises the steps of introducing labeled antibodies or labeled AFP to a biological sample of the patient so the labeled antibodies or labeled AFP will react with the AFP receptor binding sites in the biological sample. Next there is the step of identifying AFP receptor binding sites in the biological material which are reacted with the labeled antibodies or labeled AFP to determine the presence of cancer. Preferably, before the introducing step, there is the step of obtaining a biological sample from a body of a patient. A method for treating cancer cells in a patient. The method comprises the steps of introducing AFP receptor antibodies to cancer cells in the patient. Then there is the step of reacting the AFP receptor antibodies with the AFP receptor of the cancer cells to inhibit growth of the cancer cells or kill the cancer cells. A method for monitoring a patient. The method comprises the steps of treating the patient for cancer. Then there is the step of testing the patient at predetermined intervals after the treatment for AFP receptor site levels. A method for treating a patient. The method comprises the steps of testing the patient for AFP receptor. Then there is the step of introducing AFP receptor antibodies or AFP into the patient to react with cancer cells in the patient if the testing indicates AFP receptors are in the patient. A method for treating cancer cells in a patient. The method comprises the steps of introducing modified AFP to cancer cells in the patient. Then there is the step of reacting the modified AFP with the AFP receptor of the cancer cells to inhibit growth of the cancer cells or kill the cancer cells.
Patent AU-664437-B2 (AU)
Title: FO-1289 substance and its production
Inventor: OMURA SATOSHI
IPC: C12P17/18
Filed: 1993-03-26
Granted: 1995-11-16
Abstract: A FO-1289 substance of the formula   <IMAGE>   wherein R1, R2, R3 and R4 are hydrogen or acyl. A process for the production thereof comprises culturing the novel microorganism Aspergillus sp. FO-1289 FERM BP-4242 in a nutrient medium, accumulating the FO-1289 substance thus produced in the medium, and isolating the FO-1289 substance therefrom. Particular species of the FO-1289 substance comprise FO-1289A, in which R1, R2 and R3 are acetyl and R4 is hydrogen; FO-1289B, wherein R1 is propionyl, R2 and R3 are acetyl and R4 is hydrogen; FO-1289C, wherein R1 and R3 are acetyl, R2 is propionyl and R4 is hydrogen; and FO-1289D, wherein R1 and R2 are acetyl, R3 is propionyl and R4 is hydrogen.
Patent AU-699659-B2 (AU)
Title: Flexible translucent polyamide-based composition, process for its conversion and articles obtained from this composition
Inventor: LADOUCE BEATRICE
IPC: C08L77/02
Filed: 1995-11-21
Granted: 1998-12-10
Abstract: A translucent, flexible compsn. contains: (A) 50-95 wt.% of (1) a polyamide resin (PA) with light transmission at 700 nm above 15% (above 30%) (1 mm plate), (2) additives, e.g. stabilisers, demoulding agents, lubricants, crystallisation accelerators, pigments, dyes, organic and/or mineral fillers, and antioxidants, and (3) 0-50% (less than 20%), w.r.t. (A), of a plasticiser; and (B) 50-5% (10-40%) of (a) a terpolymer of ethylene, an alkyl (meth)acrylate and an anhydride of an unsatd. dicarboxylic acid, and (b) an ethylene/alkyl (meth)acrylate copolymer, in ratio of (b)/(a) or 1/30-2 (not above 2/3). The modulus of flexing (ISO 178) of the compsn. is <2/3 (<1/3) of the modulus of flexing of PA and below <750 MPa (<500 MPa).
Patent AU-661248-B2 (AU)
Title: Metal appearance composition
Inventor: RUSSO JOSEPH M
IPC: C08L75/04
Filed: 1993-03-11
Granted: 1995-07-13
Abstract: A water-based composition for spraying on a surface such as an automobile engine, to provide a flexible protective film thereon comprises a water dispersible polyurethane elastomer, an anti-corrosive agent, a thickener, a dispersing agent, an antifreeze agent, and water.
Patent AU-676831-B2 (AU)
Title: Controlled porosity expanded polytetrafluoroethylene products and fabrication
Inventor: MARTAKOS PAUL
IPC: B29C48/09
Filed: 1993-03-12
Granted: 1997-03-27
Abstract: A method of forming porous articles with a varying pore distribution by extrusion from a billet with a varying lubricant distribution. A single-polymer polytetrafluoroethylene is extruded and then stretched and sintered to provide a differential porous PTFE structure composed of fibers and nodes connected to one another by these fibers. The microfibrous structure has a portion within the cross-section that possesses a different pore size, accompanied by a different node and fiber geometry, than adjacent areas within that cross section. In a vascular graft, the pores taper inwardly, providing a fluid-tight lumen wall structure that prevents leakage, yet promotes cellular ingrowth and natural tissue regeneration. A node structure of radially-oriented plates provides flexibility, suture strength, and enhanced protection against collapse.
Patent AU-774814-B2 (AU)
Title: External retaining device for a catheter and catheter assembly and method using same
Inventor: O'HARA DEREK
IPC: A61M25/00
Filed: 2000-02-17
Granted: 2004-07-08
Abstract: An external retaining device, individually or in combination with a catheter having an elongate tube, is provided. The external retaining device includes a base member having a lower surface and an upper surface with a passage extending therethrough. A tube guide portion extending from the upper surface of the base member has two side walls with an elongate channel therebetween. The channel has a first section located proximate the passage and bends upwardly along a smooth transition to a second section angled relative to the first section. A manually-operable clip assembly is located proximate the second section of the channel. The clip assembly preferably includes opposing clip elements mounted for pivotal movement between an open position and a closed position. Preferably, pivotal movement is accomplished by forming the side walls of elastic material and affixing each clip element to a corresponding side wall, such that flexure of the side walls toward each other moves the clip elements to the open position. The elongate tube of the catheter is thereby directed through the passage and positioned within the channel to form a smooth 90° bend, and secured in place at the second section of the channel with the clip assembly moved to the closed position. An internal retaining device also can be used in combination with the external retaining device.